| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.36 | 6e-25 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-19 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-18 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.4 | 4e-16 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-15 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-13 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-13 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-12 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-11 |